A testing lab recalled more than 75,000 cases of eye drop solution after the FDA found deviations from proper manufacturing ...

Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

Corneal ulcers are most common in contact lens wearers, but they also occur as complications of many conditions. Learn what ...

Using lasers, doctors can alter cornea pigments. The FDA doesn't regulate this growing practice — is it worth it?

The cornea, which is the clear, transparent outer layer at the front of the eye, can get severely damaged during accidents ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

According to the German Ophthalmological Society (DOG), over 1.5 million eye surgeries are performed annually in the country, ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ...

For five months in 2017, farmworker Alka Kamble experienced blurred vision in one of her eyes but didn't consult an ...

NCP is a condition that causes severe pain and sensitivity of the eyes, face, or head. The exact cause is unknown but is ...

Urcosimod phase 2 trial treating Neuropathic Corneal Pain ("NCP”) patients was initiated in October 2024 and designed as a ...